Atlas Trials

Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis

Clinical trial NCT00355771 · COMPLETED

Trial details

NCT number
NCT00355771
Sponsor
Institut für Atemwegsforschung GmbH
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Allergic Rhinitis
Start date
2006-06-01
Primary completion
2007-11-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.